Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US-Reference-Cited by-同舟云学术

Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US

Published:2016-07-22 Issue:1 Volume:16 Page:
ISSN:1472-6963
Container-title:BMC Health Services Research
language:en
Short-container-title:BMC Health Serv Res

Author:

Jones E.,Pike J.,Marshall T.,Ye X.

Funder

AbbVie

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s12913-016-1532-1.pdf

Reference42 articles.

1. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372:1502–17.

2. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology. 1996;46:907–11.

3. Campbell JD, Ghushchyan V, McQueen RB, et al. Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates. Mult Scler Relat Disord. 2014;3:227–36.

4. Noseworthy J, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000;343:938–52.

5. Souza A, Kelleher A, Cooper R, Cooper RA, Iezzoni LI, Collins DM. Multiple sclerosis and mobility-related assistive technology: systematic review of the literature. J Rehabil Res Dev. 2010;47:213–23.

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences by Sexual Orientation in Patient-Centered Care Outcomes for Veterans Utilizing Primary Care Services at the Veterans Health Administration;LGBT Health;2024-09-01

2. Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV CLADFIT-MS study;Frontiers in Neurology;2024-07-18

3. Economic burden of multiple sclerosis in the United States: A systematic literature review;Journal of Managed Care & Specialty Pharmacy;2023-12

4. Brain volume loss in relapsing multiple sclerosis: Indirect treatment comparisons of available disease-modifying therapies;2023-11-20

5. Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study;Multiple Sclerosis Journal;2023-11-18